BillionToOne (BLLN) is trading up at $108.86 (+2.80%), as of the latest quote. It operates in the Health Care sector.
| FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|
| Income statement | |||
| Revenue | $71.7M | $152.6M | $305.1M |
| Growth (year over year) | — | +112.7% | +100.0% |
| Gross profit | $17.3M | $80.9M | $208.5M |
| Gross margin | 24.1% | 53.0% | 68.3% |
| Operating income | −$69.5M | −$47.1M | $16.0M |
| Operating margin | −96.9% | −30.9% | 5.3% |
| Net income | −$82.7M | −$41.6M | $7.45M |
| Net margin | −115.3% | −27.2% | 2.4% |
| EPS (diluted) | −$8.45 | −$4.12 | $0.14 |
| Balance sheet | |||
| Cash and equivalents | $97.3M | $191.5M | $496.0M |
| Total assets | — | $302.1M | $632.7M |
| Total liabilities | — | $134.3M | $152.5M |
| Long-term debt | — | $51.5M | $57.2M |
| Shareholders' equity | −$219.1M | −$251.7M | $480.1M |
| Cash flow | |||
| Operating cash flow | −$53.7M | −$41.4M | $24.6M |
| Capital expenditure | $6.17M | $5.40M | $8.88M |
| Free cash flow | −$59.8M | −$46.8M | $15.7M |
| Share buybacks | $0 | $546.0K | $0 |
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $38.4M | $45.1M | $59.0M | $66.6M | $83.5M | $96.1M | $108.4M | $109.4M |
| Growth (year over year) | — | — | — | — | +117.4% | +113.1% | +83.8% | +64.4% |
| Gross profit | $20.2M | $25.7M | $38.0M | $43.5M | $58.4M | $68.6M | $79.1M | $77.1M |
| Gross margin | 52.6% | 57.1% | 64.4% | 65.3% | 69.9% | 71.4% | 73.0% | 70.5% |
| Operating income | −$12.6M | −$11.7M | −$2.31M | −$1.63M | $9.63M | $10.3M | $17.8M | $5.50M |
| Operating margin | −32.9% | −25.9% | −3.9% | −2.4% | 11.5% | 10.8% | 16.5% | 5.0% |
| Net income | −$14.9M | −$11.5M | −$3.99M | −$246.0K | $5.71M | $5.98M | $18.0M | $8.05M |
| Net margin | −38.8% | −25.5% | −6.8% | −0.4% | 6.8% | 6.2% | 16.6% | 7.4% |
| EPS (diluted) | −$1.47 | −$1.13 | −$0.39 | −$0.02 | $0.10 | $0.45 | $0.34 | $0.15 |
| Balance sheet | ||||||||
| Cash and equivalents | $202.3M | $191.5M | $191.6M | $189.0M | $195.2M | $496.0M | $537.5M | $548.6M |
| Total assets | — | $302.1M | — | — | $327.5M | $632.7M | $700.7M | $729.7M |
| Total liabilities | — | $134.3M | — | — | $147.6M | $152.5M | $195.1M | $192.9M |
| Long-term debt | — | $51.5M | — | — | $55.0M | $57.2M | $90.0M | $91.0M |
| Shareholders' equity | −$242.9M | −$251.7M | −$252.9M | −$250.3M | −$239.5M | $480.1M | $505.6M | $536.8M |
| Cash flow | ||||||||
| Operating cash flow | — | −$8.42M | $2.63M | $1.18M | $10.00M | $10.8M | $15.4M | $9.14M |
| Capital expenditure | — | $2.07M | $2.35M | $2.87M | $2.12M | $1.54M | $4.47M | $4.05M |
| Free cash flow | — | −$10.5M | $278.0K | −$1.69M | $7.87M | $9.26M | $11.0M | $5.09M |
| Share buybacks | — | $0 | — | — | — | $0 | — | — |
From BillionToOne's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
BillionToOne chairman and CEO Atay sells $1.3 million in shares
BillionToOne chairman and CEO Atay sells $1.3 million in shares
BillionToOne SVP John ten Bosch sells $169,920 of common stock
BillionToOne SVP John ten Bosch sells $169,920 of common stock
BillionToOne CTO David Tsao sells $416,625 in stock
BillionToOne CTO David Tsao sells $416,625 in stock
BillionToOne SVP John ten Bosch sells $150,959 of class A common stock
BillionToOne SVP John ten Bosch sells $150,959 of class A common stock
BillionToOne general counsel Lynch sells $3.87m in stock
BillionToOne general counsel Lynch sells $3.87m in stock
BillionToOne SVP Sells 1,416 Shares
BillionToOne SVP Sells 1,416 Shares
BillionToOne at Wells Fargo conference: growth meets margin discipline
BillionToOne at Wells Fargo conference: growth meets margin discipline